3x vs 30x Whole-Genome Sequencing: Which One Should You Choose?
Compare 3x and 30x whole-genome sequencing, including what sequencing depth means, what each depth is best for, and how to choose the right Mito Health genome test.
If you are looking at whole-genome sequencing, one of the first questions you will see is depth: 3x, 30x, sometimes even higher.
That number matters.
Both 3x whole-genome sequencing and 30x whole-genome sequencing read across your entire genome. Neither is a fixed genotyping array that checks only a preset list of sites. The difference is how many times each position in your genome is read on average.
In simple terms, depth drives confidence.
The 3x depth gives you a light read across your whole genome. It is useful for ancestry, everyday traits, polygenic scores, and exploring the common-variant layer of your DNA. The 30x depth is the clinical-grade standard. It gives much stronger confidence for rare and pathogenic variants, carrier status, actionable ClinVar findings, and pharmacogenomics.
For many people, the decision comes down to what you want from the test.
If you want to explore your DNA, understand ancestry and traits, and own a real whole-genome file at a lower price, 3x can make sense. If you want the strongest health-oriented genome data Mito offers, 30x is the better default.
What Does 3x or 30x Mean?
The “x” refers to sequencing depth, also called coverage.
Your genome has billions of DNA letters. Sequencing technology reads DNA in fragments, then software reconstructs those reads against a reference genome. A 3x read means each position is read about three times on average. A 30x read means each position is read about thirty times on average.
More reads give the software more chances to confirm what is really there.
That matters because sequencing is probabilistic. A single read can contain noise. A region can be harder to map. Some positions may be missed or covered unevenly. When a position is read many times, there is more evidence for whether a variant is truly present, absent, or uncertain.
This is why depth matters most for rarer findings.
Common variants are easier to work with at lower depth because they are well studied, easier to impute, and often interpreted across many sites at once. Rare variants are different. If the question is whether you carry a specific rare or pathogenic variant, confidence matters more. That is where 30x pulls away from 3x.
The Short Version
| Question | 3x whole-genome sequencing | 30x whole-genome sequencing |
|---|---|---|
| Best for | Exploration, ancestry, traits, and lower-cost genome ownership | Health-oriented genome data and clinical-grade depth |
| Confident insights | Common variants, polygenic scores, ancestry, and everyday traits | Everything in 3x, plus stronger confidence for rare and pathogenic variants |
| Carrier status | Not the best depth for carrier-status confidence | Better fit for carrier-status findings |
| ClinVar-linked findings | May be visible, but not called with the same confidence | Better fit for actionable ClinVar-linked findings |
| Pharmacogenomics | Not the right depth for full medication-response genetics | Better fit for pharmacogenomics |
| Practical recommendation | Choose 3x if you mainly want curiosity, ancestry, traits, and a genome file at a lower price | Choose 30x if your main goal is health-oriented genome data |
Both depths read across the whole genome. The difference is not whether your genome is being read. The difference is how confidently the test can answer harder questions.
What 3x Whole-Genome Sequencing Is Best For
The 3x depth is best for the common-variant layer.
That includes ancestry, traits, polygenic scores, and broad exploration. If you are curious about what your DNA suggests about sleep patterns, caffeine metabolism, physical traits, ancestry-linked signals, or polygenic predispositions, 3x gives you a meaningful starting point.
It is also useful if your main goal is genome ownership.
A 3x whole-genome file is not the same as a genotyping array. Arrays check a fixed set of sites, often around hundreds of thousands of markers. Whole-genome sequencing reads across the genome itself. Even at light depth, that can give you a broader foundation for exploration than an array-based consumer DNA test.
The tradeoff is confidence on rarer findings.
At 3x, rare variants may be visible, but they should not be treated with the same confidence as a clinical-grade 30x call. That matters if your goal is health-oriented interpretation, family planning, or medication-response information.
Think of 3x as the exploration depth. It helps you start learning from your genome, especially common-variant signals, without paying for clinical-grade depth.
What 30x Whole-Genome Sequencing Is Best For
The 30x depth is the health-oriented choice.
It includes the common-variant layer that 3x can support, but adds the sequencing confidence needed for more demanding questions. That is why 30x is commonly described as clinical-grade depth.
With 30x, the main advantage is confidence on rare and pathogenic variants. This can matter for:
- Carrier status, especially if you are thinking about family planning
- ClinVar-linked findings that may be worth reviewing with a clinician
- Pharmacogenomics, where genes can affect medication response, dosing, or side-effect risk
- Health risk context that depends on specific variants rather than broad polygenic patterns
This does not mean 30x is a diagnosis.
Genome Computer is clear that this is raw data, not a medical test. Significant findings should be reviewed with a physician, genetic counselor, or clinical genetics service before being used for medical decisions.
That boundary is important. The reason to choose 30x is not that it replaces clinical care. It is that it gives you a higher-confidence data layer to bring into appropriate clinical conversations.
Why Depth Matters More for Health Questions
Not every genetic question needs the same level of confidence.
If you are looking at broad ancestry patterns or common trait associations, the analysis often draws from many common variants at once. A single missed or uncertain site may not change the whole picture.
If you are looking at a rare variant, the situation is different.
Rare-variant interpretation often depends on whether a specific position is called correctly. If a variant is linked to carrier status, medication response, or a clinically relevant finding, you want more confidence that the signal is real.
That is the practical difference between 3x and 30x.
3x can help answer: What does my common-variant layer suggest?
30x can better answer: Do I carry this specific rare or clinically relevant variant?
That is why Mito generally frames 3x as the entry point for exploration and 30x as the stronger choice for health-oriented genome data.
Is 3x Better Than a Genotyping Array?
For genome ownership and future reanalysis, yes, 3x whole-genome sequencing is a different category from a genotyping array.
A genotyping array checks selected sites. It can be useful, but it is constrained by what the array was designed to include. If a site was not on the chip, the test did not directly measure it.
Whole-genome sequencing reads across the genome. At 3x, the read is lighter and less confident for rare findings, but it still gives you a broader whole-genome data layer than a fixed chip.
That said, “better” depends on the use case.
If you want low-cost ancestry or entertainment-level trait reports, an array may be enough. If you want a portable whole-genome file that can be reanalyzed as tools improve, 3x is a more durable starting point. If you want stronger health-oriented interpretation, 30x is the better choice.
When 3x Makes Sense
Choose 3x if you are mostly curious.
It is a good fit if you want to:
- Explore ancestry and lineage
- Learn about everyday traits
- See common-variant and polygenic patterns
- Start building a personal genome file
- Keep cost lower while still getting true whole-genome sequencing
It is also a reasonable choice if you are not yet sure how deeply you want to use genome data in your health plan. You still get a whole-genome read, and you can begin learning from it without jumping straight to the clinical-grade depth.
The main limitation is that 3x should not be your first choice if your core goal is rare-variant confidence, carrier status, pharmacogenomics, or health-oriented interpretation.
When 30x Makes Sense
Choose 30x if your goal is health.
It is the better fit if you want:
- The most complete genome option Mito currently offers
- Stronger confidence for rare and pathogenic variants
- Carrier-status context
- Pharmacogenomic insights
- A data layer you may want to discuss with a clinician or genetics professional
- The strongest foundation for reanalysis over time
For most people choosing whole-genome sequencing specifically because they care about preventive health, 30x is the right default.
It costs more than 3x because it reads the genome more deeply. But if your reason for sequencing is to understand health-relevant inherited context, the extra depth is the point.
What Both Depths Have in Common
Both Mito genome options read across your whole genome.
Both are designed to give you data you can keep, download, and revisit. Both can support future analysis as genomic science changes. Both should be interpreted carefully, especially when a result could affect medical decisions.
The difference is confidence.
3x lights up the common-variant layer: ancestry, traits, polygenic scores, and personal exploration.
30x adds the clinical and pharmacogenomic layer: rare variants, carrier status, actionable ClinVar findings, and medication-response genetics.
That is the cleanest way to think about the choice.
A Practical Recommendation
If you are choosing for curiosity, start with 3x.
If you are choosing for health, choose 30x.
If you are still unsure, ask yourself one question: would I be disappointed if the test could not confidently answer rare-variant, carrier-status, or pharmacogenomic questions?
If the answer is yes, choose 30x.
If the answer is no, and your main goal is ancestry, traits, polygenic scores, and exploration, 3x is a real entry into whole-genome sequencing.
Compare Mito’s Whole-Genome Sequencing Options
Mito members can choose between:
- 3x whole-genome sequencing: best for ancestry, traits, polygenic scores, common variants, and lower-cost exploration.
- 30x whole-genome sequencing: best for clinical-grade depth, rare and pathogenic variant confidence, carrier status, ClinVar findings, and pharmacogenomics.
Depth drives confidence. Choose the depth that matches the questions you actually want your genome to answer.
